KLK3 and cancer: Welch and Albertsen argued that the conventional goal of maximizing cancer detection is insufficient; in an analysis of US incidence trends during the last 20 years, they estimated that more than a million additional men have been diagnosed and treated for PCa because of introduction of PSA screening [10].